Page 22 - Tim Mccarthy News Today

ImmuPharma receives confirmation of pre-IND meeting date with FDA for a Phase 2/3 adaptive study of P140 in CIDP 12th April 2023 - 11:41 am ImmuPharma PLC , the specialist... | April 12, 2023

The following stocks are the leading risers and fallers on AIM in London on Wednesday. ---------- AIM - WINNERS ---------- System1 Group PLC, up 17% at 189.5 pence, 12-month range 115p-295p. The... | April 12, 2023

ImmuPharma PLC - London-based drug discovery and development company - Gets confirmation of a pre-investigational new drug meeting with the US Food & Drug Administration, which will take place on... | April 12, 2023

Inchydoneys high-end Tearmann has a gym with sauna/home cinema, but the scene setter and scene-stealer is the site overlooking the ocean and one of Munsters best-loved beaches

Investegate announcements from Incanthera PLC, Result of Warrant Holder Meeting

EAGAN, Minn., April 04, 2023 -- Predictive Oncology Inc. , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive... | April 4, 2023

High Court of Justice of England and Wales Sanctions Scheme of Arrangement Acquisition of Amryt Pharma by Chiesi Farmaceutici Expected to Close Mid-April 2023 Dublin, Ireland, April 3, 2023 Amryt... | April 3, 2023

SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company...

12-month interim data from the ongoing 2-year, Phase 2 Stargardt disease (STGD1) study continues to show halting or slowing of lesion growth; 18-month...

EAGAN, Minn., March 30, 2023 -- Predictive Oncology , a science-driven company on the leading edge of oncology drug discovery and development, today announces it is partnering with... | March 30, 2023